Cardiac Resynchronization Therapy: From Epigenetic to Social Networks | Agenda Bookshop Skip to content
Online orders placed from 19/12 onward will not arrive in time for Christmas.
Online orders placed from 19/12 onward will not arrive in time for Christmas.
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Sardu Celestino
Category1=Non-Fiction
Category=MBG
Category=MJD
COP=United States
Delivery_Delivery within 10-20 working days
Language_English
PA=In stock
Price_€100 and above
PS=Active
softlaunch

Cardiac Resynchronization Therapy: From Epigenetic to Social Networks

English

Over the last few decades, cardiac resynchronization therapy (CRT) has been introduced as a choice treatment for heart failure (HF) patients, refractory to maximal drug therapy and left bundle branch block. Advanced heart failure is related to cardiac fibrosis, hypertrophy and apoptosis, and CRT in 30% of patients is not able to ameliorate cardiac performance and mechanical efficiency. This clear loss of effect (CRT failure) is frustrating and leaves HF patients in a steady and/or advanced, uncontrolled worsening state of clinical symptoms and NYHA class. Several hypotheses have been conducted to explain this loss of effect: investigating epigenetic (microRNAs activation pattern), echocardiography (mechanical cardiac dyssynchrony assessment), arrhythmias (atrial fibrillating patients), left ventricle lead positioning (target wall and vessel) and pacing modalities (bipolar vs multipolar), and epicardial approaches (cardiac surgery) to reach the target ventricular wall. The selection criteria, the implant technique and CRT monitoring are relevant aspects of the CRT world in all its complexity. The necessity to follow and characterize CRT recipients (responders vs non responders), and the routine follow up with recent advancements in technology (telemonitoring) may be an instrument to improve CRT response entity and clinical outcomes. The creation of a social platform (social networks) may represent a necessary and evolutionary step to share individual experiences and to exchange ideas about CRT recipients and experienced operators. The opportunity to improve CRT responders percentage may represent a gold standard and an attractive prospective in failing heart patients CRT recipients. In this book, we have investigated these aspects, hoping to provide to the reader the right reading tools in the CRT world. Our message remains: To help people suffering from cardiovascular diseases and to live better with their disease. See more
Current price €189.04
Original price €198.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Sardu CelestinoCategory1=Non-FictionCategory=MBGCategory=MJDCOP=United StatesDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=In stockPrice_€100 and abovePS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Weight: 364g
  • Dimensions: 155 x 230mm
  • Publication Date: 01 Sep 2016
  • Publisher: Nova Science Publishers Inc
  • Publication City/Country: United States
  • Language: English
  • ISBN13: 9781634856089
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept